Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

The cardiac syndecan-4 interactome reveals a role for syndecan-4 in nuclear translocation of muscle LIM protein (MLP).

Mathiesen SB, Lunde M, Aronsen JM, Romaine A, Kaupang A, Martinsen M, de Souza GA, Nyman TA, Sjaastad I, Christensen G, Carlson CR.

J Biol Chem. 2019 May 31;294(22):8717-8731. doi: 10.1074/jbc.RA118.006423. Epub 2019 Apr 9.

PMID:
30967474
2.

Secretoneurin Is an Endogenous Calcium/Calmodulin-Dependent Protein Kinase II Inhibitor That Attenuates Ca2+-Dependent Arrhythmia.

Ottesen AH, Carlson CR, Eken OS, Sadredini M, Myhre PL, Shen X, Dalhus B, Laver DR, Lunde PK, Kurola J, Lunde M, Hoff JE, Godang K, Sjaastad I, Pettilä V, Stridsberg M, Lehnart SE, Edwards AG, Lunde IG, Omland T, Stokke MK, Christensen G, Røsjø H, Louch WE.

Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e007045. doi: 10.1161/CIRCEP.118.007045.

PMID:
30943765
3.

Short communication: Daily intake of 125 g of cheese for 2 weeks did not alter amount or distribution of serum lipids or desaturase indexes in healthy adults in an exploratory pilot study.

Høstmark AT, Lunde MSH, Hjellset VT.

J Dairy Sci. 2018 Nov;101(11):9625-9629. doi: 10.3168/jds.2018-14635. Epub 2018 Aug 23.

PMID:
30146282
4.

Two of three patients with multiple chemical sensitivity had less symptoms and secondary hyperalgesia after transcranially applied pulsed electromagnetic fields.

Tran MTD, Skovbjerg S, Arendt-Nielsen L, Bech P, Lunde M, Elberling J.

Scand J Pain. 2014 Apr 1;5(2):104-109. doi: 10.1016/j.sjpain.2013.11.008.

PMID:
29913674
5.

Mapping the in vitro interactome of cardiac sodium (Na+ )-calcium (Ca2+ ) exchanger 1 (NCX1).

Lubelwana Hafver T, Wanichawan P, Manfra O, de Souza GA, Lunde M, Martinsen M, Louch WE, Sejersted OM, Carlson CR.

Proteomics. 2017 Sep;17(17-18). doi: 10.1002/pmic.201600417.

PMID:
28755400
6.

Development of a high-affinity peptide that prevents phospholemman (PLM) inhibition of the sodium/calcium exchanger 1 (NCX1).

Wanichawan P, Hodne K, Hafver TL, Lunde M, Martinsen M, Louch WE, Sejersted OM, Carlson CR.

Biochem J. 2016 Aug 1;473(15):2413-23. doi: 10.1042/BCJ20160465. Epub 2016 May 31.

7.

Protein Phosphatase 1c Associated with the Cardiac Sodium Calcium Exchanger 1 Regulates Its Activity by Dephosphorylating Serine 68-phosphorylated Phospholemman.

Hafver TL, Hodne K, Wanichawan P, Aronsen JM, Dalhus B, Lunde PK, Lunde M, Martinsen M, Enger UH, Fuller W, Sjaastad I, Louch WE, Sejersted OM, Carlson CR.

J Biol Chem. 2016 Feb 26;291(9):4561-79. doi: 10.1074/jbc.M115.677898. Epub 2015 Dec 14.

8.

Relapse Prevention in Major Depressive Disorder After Successful Acute Electroconvulsive Treatment: a 6-month Double-blind Comparison of Three Fixed Dosages of Escitalopram and a Fixed Dose of Nortriptyline - Lessons from a Failed Randomised Trial of the Danish University Antidepressant Group (DUAG-7).

Martiny K, Larsen ER, Licht RW, Nielsen CT, Damkier P, Refsgaard E, Lunde M, Straasø B, Christensen EM, Lolk A, Holmskov J, Sørensen CH, Brødsgaard I, Eftekhari SZ, Bendsen BB, Klysner R, Terp IM, Larsen JK, Vestergaard P, Buchholtz PE, Gram LF, Bech P; Danish University Antidepressant Group (DUAG*).

Pharmacopsychiatry. 2015 Nov;48(7):274-8. doi: 10.1055/s-0035-1565063. Epub 2015 Nov 3.

PMID:
26529118
9.
10.

Maintained superiority of chronotherapeutics vs. exercise in a 20-week randomized follow-up trial in major depression.

Martiny K, Refsgaard E, Lund V, Lunde M, Thougaard B, Lindberg L, Bech P.

Acta Psychiatr Scand. 2015 Jun;131(6):446-57. doi: 10.1111/acps.12402. Epub 2015 Feb 17.

PMID:
25689725
11.

Molecular basis of calpain cleavage and inactivation of the sodium-calcium exchanger 1 in heart failure.

Wanichawan P, Hafver TL, Hodne K, Aronsen JM, Lunde IG, Dalhus B, Lunde M, Kvaløy H, Louch WE, Tønnessen T, Sjaastad I, Sejersted OM, Carlson CR.

J Biol Chem. 2014 Dec 5;289(49):33984-98. doi: 10.1074/jbc.M114.602581. Epub 2014 Oct 21.

12.

The Diagnostic Apathia Scale predicts a dose-remission relationship of T-PEMF in treatment-resistant depression.

Bech P, Lunde M, Lauritzen L, Straasø B, Lindberg L, Vinberg M, Undén M, Hellström LC, Dissing S, Larsen ER.

Acta Neuropsychiatr. 2015 Feb;27(1):1-7. doi: 10.1017/neu.2014.26. Epub 2014 Oct 2.

PMID:
25273893
13.

Dose-remission of pulsating electromagnetic fields as augmentation in therapy-resistant depression: a randomized, double-blind controlled study.

Straasø B, Lauritzen L, Lunde M, Vinberg M, Lindberg L, Larsen ER, Dissing S, Bech P.

Acta Neuropsychiatr. 2014 Oct;26(5):272-9. doi: 10.1017/neu.2014.5.

PMID:
25241755
14.

Psychometric analysis of the Melancholia Scale in trials with non-pharmacological augmentation of patients with therapy-resistant depression.

Bech P, Lauritzen L, Lunde M, Unden M, Hellström LC, Csillag C, Martiny K.

Acta Neuropsychiatr. 2014 Jun;26(3):155-60. doi: 10.1017/neu.2013.51.

PMID:
25142191
15.

Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization.

Lunde ML, Roman E, Warnakulasuriya S, Mehrotra R, Laranne J, Vasstrand EN, Ibrahim SO.

Cancer Genomics Proteomics. 2014 May-Jun;11(3):127-40.

PMID:
24969693
16.

The day-to-day acute effect of wake therapy in patients with major depression using the HAM-D6 as primary outcome measure: results from a randomised controlled trial.

Martiny K, Refsgaard E, Lund V, Lunde M, Sørensen L, Thougaard B, Lindberg L, Bech P.

PLoS One. 2013 Jun 28;8(6):e67264. doi: 10.1371/journal.pone.0067264. Print 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/3dcdb46a-e2b7-4305-8025-ce267688e9d6.

17.

Increased serum triglycerides and reduced HDL cholesterol in male rats after intake of ammonium chloride for 3 weeks.

Høstmark AT, Lunde MS, Haug A.

Lipids Health Dis. 2013 Jun 25;12:92. doi: 10.1186/1476-511X-12-92.

18.

Analysis of protein expression profile of oral squamous cell carcinoma by MALDI-TOF-MS.

Roman E, Lunde ML, Miron T, Warnakulasauriya S, Johannessen AC, Vasstrand EN, Ibrahim SO.

Anticancer Res. 2013 Mar;33(3):837-45.

PMID:
23482752
19.

A 9-week randomized trial comparing a chronotherapeutic intervention (wake and light therapy) to exercise in major depressive disorder patients treated with duloxetine.

Martiny K, Refsgaard E, Lund V, Lunde M, Sørensen L, Thougaard B, Lindberg L, Bech P.

J Clin Psychiatry. 2012 Sep;73(9):1234-42. doi: 10.4088/JCP.11m07625.

PMID:
23059149
20.

Bilateral traumatic expulsive aniridia after phacoemulsification.

Oltra EZ, Chow CC, Lunde MW.

Middle East Afr J Ophthalmol. 2012 Jul-Sep;19(3):334-6. doi: 10.4103/0974-9233.97948.

21.

A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.

Martiny K, Lunde M, Bech P, Plenge P.

Nord J Psychiatry. 2012 Jun;66(3):147-54. doi: 10.3109/08039488.2012.674553. Epub 2012 Mar 29.

PMID:
22458638
22.

Slow post meal walking reduces the blood glucose response: an exploratory study in female Pakistani immigrants.

Lunde MS, Hjellset VT, Høstmark AT.

J Immigr Minor Health. 2012 Oct;14(5):816-22. doi: 10.1007/s10903-012-9574-x.

PMID:
22270150
23.
24.

Cheese can reduce indexes that estimate fatty acid desaturation. Results from the Oslo Health Study and from experiments with human hepatoma cells.

Høstmark AT, Lunde MS.

Appl Physiol Nutr Metab. 2012 Feb;37(1):31-9. doi: 10.1139/h11-123. Epub 2011 Dec 12.

PMID:
22148892
25.

Slowed relaxation and preserved maximal force in soleus muscles of mice with targeted disruption of the Serca2 gene in skeletal muscle.

Sjåland C, Lunde PK, Swift F, Munkvik M, Ericsson M, Lunde M, Boye S, Christensen G, Ellingsen Ø, Sejersted OM, Andersson KB.

J Physiol. 2011 Dec 15;589(Pt 24):6139-55. doi: 10.1113/jphysiol.2011.211987. Epub 2011 Sep 26.

26.

Variations in postprandial blood glucose responses and satiety after intake of three types of bread.

Lunde MS, Hjellset VT, Holmboe-Ottesen G, Høstmark AT.

J Nutr Metab. 2011;2011:437587. doi: 10.1155/2011/437587. Epub 2011 May 31.

28.

Identifying patients with therapy-resistant depression by using factor analysis.

Andreasson K, Liest V, Lunde M, Martiny K, Unden M, Dissing S, Bech P.

Pharmacopsychiatry. 2010 Nov;43(7):252-6. doi: 10.1055/s-0030-1263166. Epub 2010 Sep 6.

PMID:
20821367
29.

The Response of Enterococcus faecalis V583 to Chloramphenicol Treatment.

Aakra A, Vebø H, Indahl U, Snipen L, Gjerstad O, Lunde M, Nes IF.

Int J Microbiol. 2010;2010:483048. doi: 10.1155/2010/483048. Epub 2010 Jun 15.

30.

Gene expression analysis by cDNA microarray in oral cancers from two Western populations.

Lunde ML, Warnakulasuriya S, Sand L, Hirsch JM, Vasstrand EN, Ibrahim SO.

Anticancer Res. 2010 Apr;30(4):1083-91.

PMID:
20530413
31.

Transcranial low voltage pulsed electromagnetic fields in patients with treatment-resistant depression.

Martiny K, Lunde M, Bech P.

Biol Psychiatry. 2010 Jul 15;68(2):163-9. doi: 10.1016/j.biopsych.2010.02.017. Epub 2010 Apr 10.

PMID:
20385376
32.

The clinical effect of clomipramine in chronic idiopathic pain disorder revisited using the Spielberger State Anxiety Symptom Scale (SSASS) as outcome scale.

Bech P, Gormsen L, Loldrup D, Lunde M.

J Affect Disord. 2009 Dec;119(1-3):43-51. doi: 10.1016/j.jad.2009.03.007. Epub 2009 Apr 5.

PMID:
19349078
33.

High cortisol awakening response is associated with an impairment of the effect of bright light therapy.

Martiny K, Lunde M, Undén M, Dam H, Bech P.

Acta Psychiatr Scand. 2009 Sep;120(3):196-202. doi: 10.1111/j.1600-0447.2009.01359.x. Epub 2009 Feb 12.

PMID:
19222404
34.

A validation analysis of two self-reported HAM-D6 versions.

Bech P, Wilson P, Wessel T, Lunde M, Fava M.

Acta Psychiatr Scand. 2009 Apr;119(4):298-303. doi: 10.1111/j.1600-0447.2008.01289.x. Epub 2008 Nov 17.

PMID:
19032701
35.

Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial.

Bretlau LG, Lunde M, Lindberg L, Undén M, Dissing S, Bech P.

Pharmacopsychiatry. 2008 Mar;41(2):41-7. doi: 10.1055/s-2007-993210.

PMID:
18311683
36.

Psychiatric outcome studies (POS): does treatment help the patients? A Popperian approach to research in clinical psychiatry.

Bech P, Lunde M, Bech-Andersen G, Lindberg L, Martiny K.

Nord J Psychiatry. 2007;61 Suppl 46:4-34. No abstract available.

PMID:
17365777
37.

Patients who develop epilepsy during extended treatment with electroconvulsive therapy.

Rasmussen KG, Lunde ME.

Seizure. 2007 Apr;16(3):266-70. Epub 2006 Dec 20.

38.

Electroconvulsive therapy in patients with epilepsy.

Lunde ME, Lee EK, Rasmussen KG.

Epilepsy Behav. 2006 Sep;9(2):355-9. Epub 2006 Jul 28.

PMID:
16876485
39.

The lack of sustained effect of bright light, after discontinuation, in non-seasonal major depression.

Martiny K, Lunde M, Undén M, Dam H, Bech P.

Psychol Med. 2006 Sep;36(9):1247-52. Epub 2006 Jun 7. Erratum in: Psychol Med. 2006 Sep;36(9):1336.

PMID:
16756691
40.

Adjunctive bright light in non-seasonal major depression: results from clinician-rated depression scales.

Martiny K, Lunde M, Undén M, Dam H, Bech P.

Acta Psychiatr Scand. 2005 Aug;112(2):117-25.

PMID:
15992393
41.

Choline-binding protein D (CbpD) in Streptococcus pneumoniae is essential for competence-induced cell lysis.

Kausmally L, Johnsborg O, Lunde M, Knutsen E, Håvarstein LS.

J Bacteriol. 2005 Jul;187(13):4338-45.

42.

Adjunctive bright light in non-seasonal major depression: results from patient-reported symptom and well-being scales.

Martiny K, Lunde M, Undén M, Dam H, Bech P.

Acta Psychiatr Scand. 2005 Jun;111(6):453-9.

PMID:
15877712
43.

Effects of diverse environmental conditions on {phi}LC3 prophage stability in Lactococcus lactis.

Lunde M, Aastveit AH, Blatny JM, Nes IF.

Appl Environ Microbiol. 2005 Feb;71(2):721-7.

44.

Decreasing TSH levels in patients with Seasonal Affective Disorder (SAD) responding to 1 week of bright light therapy.

Martiny K, Simonsen C, Lunde M, Clemmensen L, Bech P.

J Affect Disord. 2004 Apr;79(1-3):253-7.

PMID:
15023503
45.

Relapse prevention by citalopram in SAD patients responding to 1 week of light therapy. A placebo-controlled study.

Martiny K, Lunde M, Simonsen C, Clemmensen L, Poulsen DL, Solstad K, Bech P.

Acta Psychiatr Scand. 2004 Mar;109(3):230-4.

PMID:
14984396
47.
48.

Transcriptional analysis of the genetic elements involved in the lysogeny/lysis switch in the temperate lactococcal bacteriophage phiLC3, and identification of the Cro-like protein ORF76.

Blatny JM, Ventura M, Rosenhaven EM, Risøen PA, Lunde M, Brüssow H, Nes IF.

Mol Genet Genomics. 2003 Jul;269(4):487-98. Epub 2003 May 21.

PMID:
12759744
49.

A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients.

Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P.

Psychosomatics. 2003 May-Jun;44(3):216-21. Erratum in: Psychosomatics. 2004 Jan-Feb;45(1):91.

PMID:
12724503
50.

Platelet serotonin transporter in stroke patients.

Rasmussen A, Christensen J, Clemmensen PM, Dalsgaard NJ, Dam H, Hindberg I, Lunde M, Plenge P, Mellerup E.

Acta Neurol Scand. 2003 Feb;107(2):150-3.

PMID:
12580867

Supplemental Content

Support Center